Celyad Oncology SA
XBRU:CYAD
Celyad Oncology SA
XBRU:CYAD
Price:
0.32
EUR
1.91%
Market Closed
Market Cap:
€14.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Celyad Oncology SA
XBRU:CYAD
|
BE |
|
Z
|
Zhejiang JW Precision Machinery Co Ltd
SZSE:300984
|
CN |
|
Moatable Inc
OTC:MTBLY
|
US |
|
Green Thumb Industries Inc
OTC:GTBIF
|
US |
|
Beyond Air Inc
NASDAQ:XAIR
|
US |
|
T
|
Talis Biomedical Corp
NASDAQ:TLIS
|
US |
|
Sinopharm Group Co Ltd
HKEX:1099
|
CN |
|
B
|
British American Tobacco (Malaysia) Bhd
KLSE:BAT
|
MY |
|
Vaishali Pharma Ltd
NSE:VAISHALI
|
IN |
|
Archidply Industries Ltd
NSE:ARCHIDPLY
|
IN |
|
Ocugen Inc
NASDAQ:OCGN
|
US |
Multiples-Based Value
The Multiples-Based Value of one
CYAD
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 0.32 EUR,
Celyad Oncology SA
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CYAD Multiples-Based Value
LOCKED
Multiples Across Competitors
CYAD Competitors Multiples
Celyad Oncology SA Competitors
Celyad Oncology SA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| BE |
|
Celyad Oncology SA
XBRU:CYAD
|
13.3m EUR | 71.3 | -2.1 | -2.2 | -2.1 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
369.2B USD | 6 | 88.2 | 14.6 | 20.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.5B USD | 5.1 | 24.3 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
173.4B USD | 5.9 | 20.4 | 12.7 | 15.7 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
111.4B USD | 9.3 | 28.2 | 21.2 | 22.1 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.5B USD | 5.6 | 17.9 | 13.3 | 15.2 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67B AUD | 3.1 | 34 | 11.3 | 14.2 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.6B EUR | 11.3 | 36.2 | 39.3 | 40.1 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
